salmeterol xinafoate
SpainDrugs containing this active substance
-
It is used for the treatment of asthma. It contains salmeterol, which opens the airways, and fluticasone, which reduces inflammation and irritation in the lungs.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 0,250 mg salmeterol xinafoate 0,050 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat asthma and Chronic Obstructive Pulmonary Disease (COPD), helping to reduce breathing difficulties, coughing, and phlegm.
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 0,050 mg fluticasone propionate 0,500 mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to help prevent respiratory problems such as asthma in adults and adolescents aged 12 years and older.
Form: powder for inhalation, single-dose
Active substance Dosage salmeterol xinafoate 0,072 mg fluticasone propionate 0,1 mg Manufacturer: Zentiva K.S.
-
It is used to help prevent respiratory problems such as asthma in adults and adolescents aged 12 years and older. It helps prevent shortness of breath and wheezing.
Form: powder for inhalation, single-dose
Active substance Dosage salmeterol xinafoate 0,0726 mg fluticasone propionate 0,25 mg Manufacturer: Zentiva K.S.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD) in adults and adolescents aged 12 years and older.
Form: powder for inhalation, single-dose
Active substance Dosage salmeterol xinafoate 0,072 mg fluticasone propionate 0,5 mg Manufacturer: Zentiva K.S.
-
It is used to help prevent respiratory problems such as asthma, helping to prevent shortness of breath and wheezing.
Form: suspension for inhalation in pressurized container
Active substance Dosage fluticasone propionate 125 µg salmeterol xinafoate 25 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma, helping to prevent shortness of breath and wheezing.
Form: suspension for inhalation in pressurized container
Active substance Dosage fluticasone propionate 250 µg salmeterol xinafoate 25 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma, helping to avoid shortness of breath and wheezing.
Form: suspension for inhalation in pressurized container
Active substance Dosage fluticasone propionate 50 µg salmeterol xinafoate 25 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It helps prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 0,1 mg salmeterol xinafoate 0,05 mg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It helps prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 0,25 mg salmeterol xinafoate 0,05 mg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It helps to keep the airways open and reduce lung inflammation.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 0,5 mg salmeterol xinafoate 0,05 mg Manufacturer: Glaxosmithkline S.A.
-
It is used for the long-term regular treatment of airway obstruction caused by asthma and chronic bronchitis (COPD). In the case of asthma, it should be used together with anti-inflammatory treatment with glucocorticoids.
Form: suspension for inhalation in pressurized container
Active substance Dosage salmeterol xinafoate 36,3 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to relieve breathing problems in people with asthma or chronic bronchitis (COPD).
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 50 µg Manufacturer: Glaxosmithkline S.A.
-
It is used for the regular long-term treatment of airway obstruction caused by asthma and chronic bronchitis (COPD). In the case of asthma, it must be used in conjunction with another anti-inflammatory treatment.
Form: suspension for inhalation in pressurized container
Active substance Dosage salmeterol xinafoate 36,3 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to relieve breathing problems in people suffering from asthma or chronic bronchitis (COPD).
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 50 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It helps prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 50 µg/dosis fluticasone propionate 500 µg/dosis Manufacturer: Orion Corporation
-
INALADUO 25 MICROGRAMS/125 MICROGRAMS/INHALATION, SUSPENSION FOR INHALATION IN PRESSURISED CONTAINER
It is used to help prevent respiratory problems such as asthma, helping to keep the airways open and reducing inflammation and irritation in the lungs.
Form: suspension for inhalation in pressurized container
Active substance Dosage fluticasone propionate 125 µg salmeterol xinafoate 25 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma, helping to prevent shortness of breath and wheezing.
Form: suspension for inhalation in pressurized container
Active substance Dosage fluticasone propionate 250 µg salmeterol xinafoate 25 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems, such as asthma, by keeping the airways open and reducing inflammation and irritation in the lungs.
Form: suspension for inhalation in pressurized container
Active substance Dosage fluticasone propionate 50 µg salmeterol xinafoate 25 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It helps prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 100 µg salmeterol xinafoate 50 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It helps prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 250 µg salmeterol xinafoate 50 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It helps to prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 500 µg salmeterol xinafoate 50 µg Manufacturer: Glaxosmithkline S.A.
-
It is used for the long-term regular treatment of airway obstruction caused by asthma and chronic bronchitis (COPD). In the case of asthma, it should be used in combination with anti-inflammatory therapy.
Form: suspension for inhalation in pressurized container
Active substance Dosage salmeterol xinafoate 25 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to relieve breathing problems in people with asthma or chronic bronchitis (COPD).
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 50 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD) in adults and adolescents aged 12 years and older.
Form: powder for inhalation, single-dose
Active substance Dosage salmeterol xinafoate 0,073 mg fluticasone propionate 0,25 mg Manufacturer: Kern Pharma S.L.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD) in adults and adolescents aged 12 years and older.
Form: powder for inhalation, single-dose
Active substance Dosage salmeterol xinafoate 0,073 mg fluticasone propionate 0,5 mg Manufacturer: Kern Pharma S.L.
-
It is used to help prevent respiratory problems such as asthma, helping to prevent shortness of breath and wheezing.
Form: suspension for inhalation in pressurized container
Active substance Dosage salmeterol xinafoate 36,32 µg fluticasone propionate 125,00 µg Manufacturer: Cipla Europe
-
It is used to help prevent respiratory problems such as asthma, helping to prevent shortness of breath and wheezing.
Form: suspension for inhalation in pressurized container
Active substance Dosage salmeterol xinafoate 36,32 µg fluticasone propionate 250,00 µg Manufacturer: Cipla Europe
-
It is used to help prevent respiratory problems such as asthma, helping to avoid shortness of breath and wheezing.
Form: powder for inhalation, single-dose
Active substance Dosage salmeterol xinafoate 0.073 mg fluticasone propionate 0.250 mg Manufacturer: Cipla Europe N.V.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It contains a bronchodilator that keeps the airways open and a corticosteroid that reduces inflammation in the lungs.
Form: powder for inhalation, single-dose
Active substance Dosage salmeterol xinafoate 0.073 mg fluticasone propionate 0.50 mg Manufacturer: Cipla Europe N.V.
-
It is used to treat asthma in adults and adolescents aged 12 years and older, helping to prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 18,52 µg fluticasone propionate 100 µg Manufacturer: Teva B.V.
-
It is used to treat asthma in adults and adolescents aged 12 years and older, helping to prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage salmeterol xinafoate 18,52 µg fluticasone propionate 202 µg Manufacturer: Teva B.V.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It helps prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 0.5 mg salmeterol xinafoate 0.05 mg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It helps prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 0.1 mg salmeterol xinafoate 0.05 mg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems such as asthma and Chronic Obstructive Pulmonary Disease (COPD). It helps to prevent shortness of breath and wheezing.
Form: powder for inhalation
Active substance Dosage fluticasone propionate 250 µg salmeterol xinafoate 72,5 µg Manufacturer: Glaxosmithkline S.A.
-
It is used for the regular long-term treatment of airway obstruction caused by asthma and chronic bronchitis (COPD). In the case of asthma, it must be used alongside anti-inflammatory treatment.
Form: suspension for inhalation in pressurized container
Active substance Dosage salmeterol xinafoate 36,3 µg Manufacturer: Glaxosmithkline S.A.
-
It is used to help prevent respiratory problems in adults and adolescents caused by asthma. It also helps prevent respiratory problems in adults with chronic obstructive pulmonary disease (COPD).
Form: suspension for inhalation in pressurized container
Active substance Dosage salmeterol xinafoate 0,0363 mg/dosis Manufacturer: Cipla Europe N.V.